BioMarin Pharmaceutical (BMRN) operating margin
BioMarin Pharmaceutical (BMRN) had an operating margin of 12.7% in fiscal 2025 (the year ended December 31, 2025). That is 3.9 percentage points lower than the 16.6% of fiscal 2024. Figures as of 17 Nov 2026, 21:34 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Operating margin, fiscal 2025
- 12.7%
- Change on fiscal 2024
- −3.9 pts
- Highest on record
- 16.6%fiscal 2024
- Lowest on record
- -71.9%fiscal 2016
- Fiscal years on record
- 182008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
BioMarin Pharmaceutical operating margin, in more detail
Across the 18 fiscal years on record (2008–2025), the highest was 16.6% in fiscal 2024 and the lowest -71.9% in fiscal 2016. The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is -4.5%.
Gross margin was 77.7% in fiscal 2025. Net margin was 10.8% in fiscal 2025.
Operating margin by fiscal year
- Operating margin
- Gross margin
- Net margin
BioMarin Pharmaceutical operating margin, year by year
| Fiscal year | Operating margin | Change | Year ended | Gross margin | Net margin |
|---|---|---|---|---|---|
| 2025 | 12.7% | 3.9 pts down | 77.7% | 10.8% | |
| 2024 | 16.6% | 8.9 pts up | 79.7% | 15.0% | |
| 2023 | 7.7% | 4.9 pts up | 78.0% | 6.9% | |
| 2022 | 2.7% | 7.2 pts up | 76.0% | 6.8% | |
| 2021 | -4.5% | 2.1 pts down | — | -3.5% | |
| 2020 | -2.3% | 3.6 pts up | — | 45.9% | |
| 2019 | -5.9% | 2.4 pts up | — | -1.4% | |
| 2018 | -8.3% | 7.2 pts down | — | -5.2% | |
| 2017 | -1.1% | 70.8 pts up | — | -8.9% | |
| 2016 | -71.9% | 59.5 pts down | — | -56.4% | |
| 2015 | -12.4% | 0.0 pts | — | -19.3% | |
| 2014 | -12.4% | 16.0 pts up | — | -17.9% | |
| 2013 | -28.4% | 6.4 pts down | — | -32.2% | |
| 2012 | -22.0% | 14.3 pts down | — | -22.8% | |
| 2011 | -7.7% | 7.8 pts down | — | -12.2% | |
| 2010 | 0.1% | 4.9 pts down | — | 54.7% | |
| 2009 | 5.1% | 8.3 pts down | — | -0.2% | |
| 2008 | 13.4% | — | — | 10.4% |
Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
How to read it
It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.
Operating margin at health care companies of similar size
| Company | Operating margin | Fiscal year |
|---|---|---|
| Universal Health Services UHS | 11.5% | 2025 |
| Repligen RGEN | 5.6% | 2025 |
| Bio-Techne TECH | 22.4% | 2026 |
| BioMarin Pharmaceutical BMRN | 12.7% | 2025 |
| Avantor AVTR | 8.3% | 2025 |
| Ensign Group ENSG | 8.4% | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
BioMarin Pharmaceutical, figure by figure
- BioMarin Pharmaceutical market cap
- BioMarin Pharmaceutical revenue
- BioMarin Pharmaceutical earnings
- BioMarin Pharmaceutical earnings per share (EPS)
- BioMarin Pharmaceutical P/E ratio
- BioMarin Pharmaceutical P/S ratio
- BioMarin Pharmaceutical P/B ratio
- BioMarin Pharmaceutical free cash flow
- BioMarin Pharmaceutical dividend
- BioMarin Pharmaceutical shares outstanding
- BioMarin Pharmaceutical total debt
- BioMarin Pharmaceutical cash on hand
- BioMarin Pharmaceutical total assets
- BioMarin Pharmaceutical return on equity (ROE)
- BioMarin Pharmaceutical return on invested capital (ROIC)
BioMarin Pharmaceutical (BMRN) overview: price, valuation and scorecardAll health care companies by market value
BioMarin Pharmaceutical operating margin: questions and answers
What is BioMarin Pharmaceutical's operating margin?
BioMarin Pharmaceutical (BMRN) had an operating margin of 12.7% in fiscal 2025 (the year ended December 31, 2025). That is 3.9 percentage points lower than the 16.6% of fiscal 2024.
Is BioMarin Pharmaceutical's operating margin high or low compared with its own history?
The fiscal 2025 figure is higher than in 88% of the 17 earlier fiscal years on record, whose median is -4.5%.
What are the highest and lowest operating margin figures on record for BioMarin Pharmaceutical?
Across the 18 fiscal years on record (2008–2025), the highest was 16.6% in fiscal 2024 and the lowest -71.9% in fiscal 2016.
What are BioMarin Pharmaceutical's gross and net margins?
Gross margin was 77.7% in fiscal 2025. Net margin was 10.8% in fiscal 2025.
How is BioMarin Pharmaceutical's operating margin calculated?
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
Fiscal years are named for the calendar year they end in.
Learn: operating margin
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “BioMarin Pharmaceutical (BMRN) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/BMRN/operating-margin
Underlying data: the company's filings with the SEC and Yahoo Finance.